Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iridex (IRIX) EBT Margin (2016 - 2025)

Historic EBT Margin for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to 12.57%.

  • Iridex's EBT Margin rose 39800.0% to 12.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.98%, marking a year-over-year increase of 129300.0%. This contributed to the annual value of 18.17% for FY2024, which is 4800.0% up from last year.
  • Per Iridex's latest filing, its EBT Margin stood at 12.57% for Q3 2025, which was up 39800.0% from 7.17% recorded in Q2 2025.
  • Over the past 5 years, Iridex's EBT Margin peaked at 10.43% during Q3 2021, and registered a low of 29.13% during Q1 2024.
  • In the last 5 years, Iridex's EBT Margin had a median value of 15.16% in 2023 and averaged 13.45%.
  • In the last 5 years, Iridex's EBT Margin surged by 550600bps in 2021 and then crashed by -266000bps in 2022.
  • Quarter analysis of 5 years shows Iridex's EBT Margin stood at 16.26% in 2021, then soared by 52bps to 7.87% in 2022, then tumbled by -215bps to 24.83% in 2023, then soared by 73bps to 6.62% in 2024, then tumbled by -90bps to 12.57% in 2025.
  • Its last three reported values are 12.57% in Q3 2025, 7.17% for Q2 2025, and 14.07% during Q1 2025.